Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations.

The core outcomes set in disease modification trials in mild to moderate dementia should include cognition markers for all trial participants and a structural magnetic resonance imaging scan for a subset.

http://ift.tt/2uhvc1e